Continuous Subcutaneous Insulin Infusion (CSII) treatments for peoplewith type 1 diabetes can combine the use of a smart insulin pump with a Continuous GlucoseMonitor (CGM) and a control algorithm to improve the regulation of the insulin delivery. New control algorithms need to be tested in clinical trials under strictly safety conditions for the patients.
General information
Exposure date:2017
Issue date:2017
Document language:English
Event:Advanced Technologies & Treatments for Diabetes (Paris, France, 15-18 February, 2017)
Origin:Instituto de Investigaciones en Electrónica, Control y Procesamiento de Señales
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)